000504 南華生物
按盤價 
6.870 +0.030 (+0.439%)
6.870 +0.030 (+0.439%) | 2023/09 - 九個月 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.473 | -83.486 | -88.528 | 36.260 | 460.738 |
| 總資產報酬率 ROA (%) | 0.089 | -2.094 | -3.147 | 1.978 | 6.156 |
| 投入資產回報率 ROIC (%) | 0.228 | -6.195 | -12.780 | 3.605 | 23.843 | 邊際利潤分析 |
| 銷售毛利率 (%) | 67.192 | 64.792 | 70.831 | 55.525 | 62.968 |
| 營業利潤率 (%) | 4.645 | -13.052 | -19.579 | 10.790 | 12.369 |
| 息稅前利潤/營業總收入 (%) | 12.122 | -4.978 | -10.368 | 12.679 | 20.804 |
| 淨利潤/營業總收入 (%) | 4.495 | -14.855 | -21.135 | 8.336 | 13.618 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -143.651 | 32.101 | 62.241 | 104.845 | -97.468 |
| 價值變動淨收益/利潤總額(%) | 9.768 | 0.255 | 1.033 | -1.192 | 234.216 |
| 營業外收支淨額/利潤總額(%) | 17.111 | -21.290 | -1.447 | 0.127 | 4.901 | 償債能力分析 |
| 流動比率 (X) | 0.952 | 0.915 | 0.977 | 1.147 | 0.960 |
| 速動比率 (X) | 0.936 | 0.905 | 0.956 | 1.111 | 0.837 |
| 資產負債率 (%) | 84.398 | 85.556 | 83.266 | 75.819 | 57.345 |
| 帶息債務/全部投入資本 (%) | 85.200 | 85.251 | 81.178 | -- | 68.216 |
| 股東權益/帶息債務 (%) | 7.901 | 7.492 | 10.552 | 35.384 | 37.822 |
| 股東權益/負債合計 (%) | 3.116 | 2.910 | 3.031 | 6.301 | 11.967 |
| 利息保障倍數 (X) | 1.860 | -0.861 | -1.161 | 6.760 | 2.668 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 414.133 | 318.839 | 442.373 | 0.000 | 85.294 |
| 存貨周轉天數 (天) | 46.244 | 38.635 | 100.751 | 0.000 | 179.927 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 26/04/2024 12:01 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
